Inogen Inc
INGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001294133
In the last 90 days, Inogen Inc insiders filed 0 open-market purchases and 1 sale; 129 institutions reported holding it in 13F filings for Q2 2026, worth $124.3M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $72.1K in total
- 1
- 13F holdersQ2 2026, +5 vs. previous quarter
- 129
- 13F valueReported value at the end of Q2 2026
- $124.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding INGN, Q2 2026
No superinvestor reported holding INGN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Inogen Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 (view filing)4:36 PM ET | Jul 1 | 5 days | Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR Off | SSale | −10.9K | $6.60 | −$72.1K | −68.5%5.04K after | 10b5-1 |
| Jun 2, 2026 (view filing) | May 29 | 4 days | Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR Off | SSale | −10.8K | $6.53 | −$70.3K | −40.3%16.0K after | 10b5-1 |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Bourque Michael J.EVP, CFO & Treasurer | PPurchase | +3.00K | $8.32 | +$25.0K | +6.7%47.6K after | 10b5-1 |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Smith Kevin Raymond MerrillCEO and President | PPurchase | +11.7K | $8.56 | +$100.2K | +20.0%70.3K after | 10b5-1 |
| May 14, 2024 (view filing) | May 10 | 4 days | Somer JasonEVP, Gen. Counsel & Secretary | SSale | −10.0K | $8.56 | −$85.6K | −69.2%4.45K after | |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Glezer StanislavEVP, Chief Technology Officer | SSale | −1.58K | $28.16 | −$44.4K | −51.3%1.50K after | |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Somer JasonEVP, Gen. Counsel & Secretary | SSale | −1.15K | $28.16 | −$32.2K | −49.7%1.16K after | |
| Mar 7, 2022 (view filing) | Mar 3 | 4 days | Anderson Ray Benjamin MDirector | SSale | −4.52K | $34.68 | −$156.6K | −100.0%0 after | |
| Dec 3, 2021 (view filing) | Dec 15, 2020 | 353 days | Bauerlein AlisonEVP, Finance, & CFO | SSale | −8.70K | $40.16 | −$349.5K | −21.1%32.5K after | Amended3 lots |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Huggenberger RaymondDirector | SSale | −4.00K | $49.00 | −$196.0K | −18.5%17.6K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Inogen Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,748,986 | $11.3M | 0.00% | +101,902+6.2% | Added |
| Armistice Capital, LLC | 1,096,000 | $7.07M | 0.20% | −104,000−8.7% | Reduced |
| Acadian Asset Management LLC | 1,096,879 | $7.07M | 0.01% | +13,396+1.2% | Added |
| Vanguard Capital Management LLC | 1,038,316 | $6.70M | 0.00% | +1,611+0.2% | Added |
| Ameriprise Financial Inc | 983,028 | $6.34M | 0.00% | +123,485+14.4% | Added |
| AQR Capital Management LLC | 937,334 | $6.05M | 0.00% | +510,216+119.5% | Added |
| DAFNA Capital Management LLC | 845,179 | $5.45M | 1.04% | 00.0% | Unchanged |
| Arrowstreet Capital, Limited Partnership | 743,252 | $4.79M | 0.00% | +157,093+26.8% | Added |
| Morgan Stanley | 646,276 | $4.17M | 0.00% | +105,111+19.4% | Added |
| Geode Capital Management, LLC | 641,521 | $4.14M | 0.00% | +27,992+4.6% | Added |